Citations 1
Results of E1496: A phase III trial of CVP with or without maintenance rituximab in advanced indolent lymphoma (NHL)
Hochster, H. S., Weller, Edie, Gascoyne, Randy D. , Frankel, SR, Horning, SJ, Ryan, Thomas M. , Habermann, Thomas M.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6502-6502
